Literature DB >> 14688052

Available clinical markers of treatment outcome integrated in mathematical models to guide therapy in HIV infection.

Elisabeta Vergu1, Alain Mallet, Jean-Louis Golmard.   

Abstract

Because treatment failure in many HIV-infected persons may be due to multiple causes, including resistance to antiretroviral agents, it is important to better tailor drug therapy to individual patients. This improvement requires the prediction of treatment outcome from baseline immunological or virological factors, and from results of resistance tests. Here, we review briefly the available clinical factors that have an impact on therapy outcome, and discuss the role of a predictive modelling approach integrating these factors proposed in a previous work. Mathematical and statistical models could become essential tools to address questions that are difficult to study clinically and experimentally, thereby guiding decisions in the choice of individualized drug regimens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688052     DOI: 10.1093/jac/dkh024

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

Review 1.  Economic models of antiretroviral therapy: searching for the optimal strategy.

Authors:  Fred J Hellinger
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc.

Authors:  Philippe Jacqmin; Lynn McFadyen; Janet R Wade
Journal:  Br J Clin Pharmacol       Date:  2008-04       Impact factor: 4.335

3.  Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.

Authors:  Neil Benson; Joost de Jongh; Jonathan D Duckworth; Hannah M Jones; Henry E Pertinez; Jaiessh K Rawal; Tamara J van Steeg; Piet H Van der Graaf
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.